Good news on reinfection front: US NIH researchers found that people with SARS-CoV-2 antibodies showed “substantial” immunity to the virus at least for a few months,
Early in the pandemic, the dominant COVID-19 forecasting systems produced pretty patchy results. Then, with no formal training in medicine or epidemiology, data scientist Youyang Gu built his his own model. He took on heavyweights like the Institute for Health Metrics and…
We’re not sure—but there are promising clues with new results expected in the coming weeks,
Good News: A new collaboration is seeking to upend the current gene therapies approach for sickle cell disease.
Health workers forced to reuse N95 respirators designed to be disposable have been a hallmark of pandemic supply shortages. A year on, US hospitals are still rationing N95s despite significantly ramped up production.
As vaccination programs race to get ahead of more contagious new coronavirus variants, will rapid tests be a linchpin of success?
The biggest COVID-19 treatment trial yet has found that an anti-inflammatory drug tocilizumab reduced the risk of death for people hospitalized with the disease, shortened hospital stays, and cut the need for mechanical ventilation,
The Carter Foundation has announced substantial progress toward the goal of eradicating Guinea worm by 2030. In 2020—despite the pandemic—human Guinea worm cases fell to just 27 worldwide. That’s a 50% drop from the previous year.
About 50 anti-vaccine protesters shut down a mass vaccination site at Dodger Stadium in Los Angeles on Saturday afternoon,
“The world was not as prepared as it should have been, and it must do better,” concludes a WHO panel reviewing the pandemic response in an